Dr. Ho's research on viral replication, and on HIV at the molecular and cellular level, is also an outstanding example of the interplay of basic science and its applications. Working with mathematicians, he used his early clinical studies on the action of protease inhibitors to expose the dynamic nature of HIV replication in vivo, and to advance the basic understanding of HIV at the molecular level. These breakthroughs were the basis for his pioneering of effective combination therapies, which have dramatically lowered AIDS mortality in developed countries, and have replaced despair by hope for so many. Dr. Ho has developed as well candidate AIDS vaccines, now being tested.

A graduate of Caltech and Harvard Medical School, Dr. Ho has held academic appointments at UCLA, NYU and Rockefeller University, and is currently the Scientific Director and Chief Executive Officer of The Aaron Diamond AIDS Research Center there. Time Magazine's Man of the Year in 1996, and a holder of many honorary degrees, Dr. Ho is a member of the Institute of Medicine of the National Academy of Sciences.